Study of NTLA-2001 for Patients with Transthyretin Amyloidosis and Heart Disease
- Substances:DexamethasoneFamotidine+4
Norway- Participants:18–64 years · 65+ years
- Substances:Dexamethasone
- Sponsor:Intellia Therapeutics Inc.
Rare diseases
Investigational molecules
Locations
Back to Norway527 clinical trials in Oslo, Norway across 9 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in NorwayKliniske-Studier.no(opens in a new tab)
NorwayStudy of Dapagliflozin to Preserve Function in Transplanted Kidneys
NorwayStudy of Sacituzumab Tirumotecan and Pembrolizumab for Patients with Triple-Negative Breast Cancer Post-Surgery
NorwayStudy Comparing Nemtabrutinib, Ibrutinib, and Acalabrutinib for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
NorwayStudy on Enalapril for Adults with Painful Venous Malformations
NorwayStudy of Tranexamic Acid Applied to Surgical Wounds to Prevent Bleeding Complications After Plastic Surgery in Adult Patients
NorwayStudy on the Effectiveness of Concizumab for Children Under 12 with Hemophilia A or B, With or Without Inhibitors
NorwayStudy of Lenvatinib, Pembrolizumab, and Chemotherapy Combination for Patients with Advanced Esophageal Cancer Previously Treated with PD-1/PD-L1 Therapy
NorwayStudy on the Effects of Zasocitinib for Patients with Moderate to Severe Crohn's Disease
NorwayStudy of Teclistamab and Lenalidomide as Maintenance Treatment for Newly Diagnosed Multiple Myeloma Patients After Stem Cell Transplantation
NorwayStudy on the Long-term Safety of Guselkumab for Children with Crohn's Disease, Ulcerative Colitis, or Juvenile Psoriatic Arthritis
NorwayStudy of TL-895 for Patients with Relapsed or Refractory Myelofibrosis or Indolent Systemic Mastocytosis
NorwayThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on pulmonary conditions and respiratory health, including studies on idiopathic pulmonary fibrosis and respiratory syncytial virus prevention in children.
Innovative therapies being tested to improve lung function and patient outcomes.
Studies examining heart conditions and vascular health, with particular focus on heart failure and cardiovascular disease prevention.
Advanced imaging techniques and therapeutic interventions being evaluated for cardiac conditions.
Comprehensive research into various cancer treatments, including trials for gastric, esophageal, and rare cancers.
Novel therapeutic approaches combining immunotherapy with conventional treatments.
Tell us about your condition – we search every trial in Europe and connect you with the right site.